De Brauw and hollandbio to host event on scaling beyond Series C

Hollandbio and De Brauw Blackstone Westbroek are hosting an exclusive session on scaling beyond Series C. As biotech companies enter later stages of growth, the rules of the game change. Financing rounds become more complex, investor expectations intensify and governance frameworks require further development. How do companies successfully navigate through this next phase of growth?

During this afternoon session, investors, bankers, lawyers and biotech leaders will share their insights and real-world experiences of late-stage financing. The programme offers insight into strategies for attracting growth capital as well as the legal, financial, and strategic considerations that come with scaling beyond Series C.

Interested in joining us? Please register here via the hollandbio website.